+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of active ulcerative colitis with a recombinant humanised antibody to alpha-4 integrin



Treatment of active ulcerative colitis with a recombinant humanised antibody to alpha-4 integrin



Gut 44(SUPPL 1): A36




(PDF emailed within 1 workday: $29.90)

Accession: 035980734

Download citation: RISBibTeXText


Related references

A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin. Alimentary Pharmacology & Therapeutics 16(4): 699-705, 2002

Randomised double-blind placebo-controlled trial of recombinant humanised antibody to alpha-4 integrin in active Crohns disease. Gut 44(SUPPL 1): A42, 1999

Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial. Gut 55(11): 1568-1574, 2006

Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomized, double blind, placebo controlled, dose ranging trial. Yearbook of Gastroenterology 2007: 125-126, 2007

Anti-TNF-alpha antibody treatment of patients with active ulcerative colitis. Ugeskrift for Laeger 169(9): 789-791, 2007

A randomised, double-blind, placebo-controlled, pan-European study of a recombinant humanised antibody to alpha4 integrin in moderate to severely active Crohns disease. Gastroenterology 120(5 Supplement 1): A 127-A 128, 2001

Treatment of Ulcerative Colitis With a Humanized Antibody to the α4β7 Integrin. Yearbook of Pediatrics 2007: 168-170, 2007

Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin. New England Journal of Medicine 352(24): 2499-2507, 2005

Effective treatment of mouse experimental colitis by alpha 2 integrin antibody: comparison with alpha 4 antibody and conventional therapy. Acta Physiologica 207(2): 326-336, 2013

Antibody to alpha4beta7 integrin for ulcerative colitis. New England Journal of Medicine 353(11): 1180-1; Author Reply 1180-1, 2005

Treatment of ulcerative colitis with an engineered human anti-TNF-alpha antibody CDP571. Gastroenterology 110(4 SUPPL ): A905, 1996

Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha. Gut 40(5): 628-633, 1997

Treatment of ulcerative colitis in the cottontop tamarin using anti-tumour necrosis factor alpha antibody. Gastroenterology 106(4 SUPPL ): A792, 1994

Humanized antibody to the alpha4beta7 integrin for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2009(1): Cd007571, 2009

AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial. Journal of Crohn's and Colitis 10(6): 631-640, 2017